Pharmaids Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Pharmaids Pharmaceuticals Ltd. on BSE

Load latest

Pharmaids Pharmaceuticals Ltd.

26 Sep 2024

57.34

-2.78%

AGM

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Voting results along with scrutinizer''s report of the 35th Annual General Meeting of the Company held on 25 September 2024 at 11.30 AM though VC/OAVM.

pdf

Pharmaids Pharmaceuticals Ltd.

25 Sep 2024

57.34

-2.78%

AGM

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Outcome of the 35th Annual General Meeting of the Company held on 25, September 2024, i.e., Today, at 11:30 a.m. through VC/OAVM.

pdf

Pharmaids Pharmaceuticals Ltd.

13 Sep 2024

57.34

-2.78%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 30 SEBI (LODR) - Intimation On Loan …

BSE India

Disclosure of Information under Regulation 30 of SEBI (LODR) Regulations, 2015, Intimation on Loan Agreement.

pdf

Pharmaids Pharmaceuticals Ltd.

04 Sep 2024

57.34

-2.78%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In accordance with Regulation 47 and other applicable regulations, if any of the SEBI (LODR) Regulations, 2015, please find enclosed the copy of the Newspaper Advertisement published on September 04, 2024, intimating the Notice of 35th Annual General Meeting of the Company.

pdf

Pharmaids Pharmaceuticals Ltd.

03 Sep 2024

57.34

-2.78%

Corp. Note

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Reg. 34 (1) Annual Report.

BSE India

We are hereby submitting the Annual Report for the Financial Year 2023-24 of the Company in compliance with the applicable Act and Regulation as amended from time to time for your record and dissemination.

pdf

Pharmaids Pharmaceuticals Ltd.

03 Sep 2024

57.34

-2.78%

AGM

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Notice Of Convening The 35Th Annual General Meeting (AGM)

BSE India

The 35th Annual General Meeting of the Company is scheduled to be held on Wednesday, 25th September 2024 at 11.30 AM through VC/OAVM. Please find the Annual Report for the FY 2023-24 containing notice of the AGM for your record and dissemination.

pdf

Pharmaids Pharmaceuticals Ltd.

28 Aug 2024

57.34

-2.78%

Board Meeting

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Outcome for Board Meeting Outcome For Approval Of …

BSE India

Outcome of the Board Meeting held on 28th August 2024, for approval of Annual Financial Statements for the financial year 2023-24 and AGM related matters.

pdf

Pharmaids Pharmaceuticals Ltd.

27 Aug 2024

57.34

-2.78%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 30 (LODR)- Intimation On Loan Agreement

BSE India

Disclosure of Information under regulation 30 of SEBI (LODR) Regulations, 2015 - Intimation on Loan Agreement.

pdf

Pharmaids Pharmaceuticals Ltd.

20 Aug 2024

57.34

-2.78%

Board Meeting

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Intimation for Approval Of Notice Of 35Th Annual …

BSE India

PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2024 ,inter alia, to consider and approve the Audited Financial Statements (Standalone & Consolidated) for the year ended 31st March 2024, the Director''s Report for the year ended 31st March 2024 , Notice of 35th Annual General Meeting(AGM)and other AGM related matters.

pdf

Pharmaids Pharmaceuticals Ltd.

14 Aug 2024

57.34

-2.78%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI Listing Regulations, 2015, enclosed herewith the copies of Newspaper Publications providing extracts of Unaudited Financial Results for the quarter ended June 30, 2024.

pdf

Is Pharmaids Pharmaceuticals Ltd. worth buying?

13 Votes:

Buy 53.85%

Sell 30.77%

Hold 15.38%